Literature DB >> 2684646

Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells.

J Plouët1, J Schilling, D Gospodarowicz.   

Abstract

An endothelial cell growth factor with unique specificity for vascular endothelial cells has been purified from the conditioned medium of the AtT-20 pituitary cell line. This growth factor, which has been characterized as a homodimer composed of two subunits with mol. wts of 23 kd is a potent mitogen for vascular endothelial cells in vitro with activity detectable at 50 pg/ml and saturation at 1 ng/ml. It was also angiogenic in vivo. In contrast with other endothelial mitogens of the fibroblast growth factor family, it has a unique target cell specificity. It did not stimulate the growth of other cell types of the vascular system such as vascular smooth muscle cells or that of mesoderm and neuroectoderm derived cells. Microsequencing revealed an amino-terminal sequence with no homology to any known protein. The release of this novel endothelial cell growth factor by pituitary derived cells and its unique target cell specificity suggest that it could play an important role in the angiogenic process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684646      PMCID: PMC402066          DOI: 10.1002/j.1460-2075.1989.tb08557.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  Rapid and sensitive protein similarity searches.

Authors:  D J Lipman; W R Pearson
Journal:  Science       Date:  1985-03-22       Impact factor: 47.728

2.  Stimulation of corneal endothelial cell proliferations in vitro by fibroblast and epidermal growth factors.

Authors:  D Gospodarowicz; A L Mescher; C R Birdwell
Journal:  Exp Eye Res       Date:  1977-07       Impact factor: 3.467

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Neovascular responses induced by cultured aortic endothelial cells.

Authors:  S A Harris-Hooker; C M Gajdusek; T N Wight; S M Schwartz
Journal:  J Cell Physiol       Date:  1983-03       Impact factor: 6.384

5.  Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor.

Authors:  D Gospodarowicz; J Cheng; G M Lui; A Baird; P Böhlent
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines.

Authors:  B E Weissman; S A Aaronson
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

7.  Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors.

Authors:  M Klagsbrun; Y Shing
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

8.  Control of bovine adrenal cortical cell proliferation by fibroblast growth factor. Lack of effect of epidermal growth factor.

Authors:  D Gospodarowicz; C R Ill; P J Hornsby; G N Gill
Journal:  Endocrinology       Date:  1977-04       Impact factor: 4.736

9.  Secretory granules of an anterior pituitary cell line, AtT-20, contain only mature forms of corticotropin and beta-lipotropin.

Authors:  B Gumbiner; R B Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

10.  Bovine brain and pituitary fibroblast growth factors: comparison of their abilities to support the proliferation of human and bovine vascular endothelial cells.

Authors:  D Gospodarowicz; J Cheng; M Lirette
Journal:  J Cell Biol       Date:  1983-12       Impact factor: 10.539

View more
  88 in total

1.  The role of the vascular phase in solid tumor growth: a historical review.

Authors:  D Ribatti; A Vacca; F Dammacco
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis.

Authors:  Jörg Wilting; Bodo Christ; Li Yuan; Anne Eichmann
Journal:  Naturwissenschaften       Date:  2003-09-17

Review 3.  Interferons as antiangiogenic agents.

Authors:  Daniel J Lindner
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

4.  The effects of growth factors on the day 13 chorioallantoic membrane (CAM): a study of VEGF165 and PDGF-BB.

Authors:  J Wilting; B Christ; H A Weich
Journal:  Anat Embryol (Berl)       Date:  1992-08

5.  Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress.

Authors:  Brian R Hoffmann; Jordan R Wagner; Anthony R Prisco; Agnieszka Janiak; Andrew S Greene
Journal:  Physiol Genomics       Date:  2013-09-10       Impact factor: 3.107

6.  Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.

Authors:  D Shweiki; A Itin; G Neufeld; H Gitay-Goren; E Keshet
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Sonoporation of the minicircle-VEGF(165) for wound healing of diabetic mice.

Authors:  C S Yoon; H S Jung; M J Kwon; S H Lee; C W Kim; M K Kim; M Lee; J H Park
Journal:  Pharm Res       Date:  2008-11-08       Impact factor: 4.200

Review 8.  Therapeutic potential of manipulating VEGF splice isoforms in oncology.

Authors:  Emma S Rennel; Steven J Harper; David O Bates
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

9.  Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.

Authors:  B Witzenbichler; T Asahara; T Murohara; M Silver; I Spyridopoulos; M Magner; N Principe; M Kearney; J S Hu; J M Isner
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 10.  Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants.

Authors:  G Neufeld; T Cohen; H Gitay-Goren; Z Poltorak; S Tessler; R Sharon; S Gengrinovitch; B Z Levi
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.